Cargando…
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions
In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral load peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 (COVID-19) is marked by aberrant innate and adaptive immune responses with an abnormal cytokine profile and multiorgan system dy...
Autores principales: | Meyerowitz, Eric A, Sen, Pritha, Schoenfeld, Sara R, Neilan, Tomas G, Frigault, Matthew J, Stone, John H, Kim, Arthur Y, Mansour, Michael K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717185/ https://www.ncbi.nlm.nih.gov/pubmed/33216852 http://dx.doi.org/10.1093/cid/ciaa1759 |
Ejemplares similares
-
Coronavirus Disease 2019 (COVID-19), Organ Transplantation, and the Nuances of Immunomodulation: Lessons Learned and What Comes Next
por: Haidar, Ghady
Publicado: (2020) -
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020) -
Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis
por: Zeng, Chengbo, et al.
Publicado: (2022) -
Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019
por: Haidar, Ghady, et al.
Publicado: (2021) -
Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores
por: Hoenigl, Martin
Publicado: (2020)